EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Percutaneous closure of a giant left ventricular pseudoaneurysm using an Amplatzer muscular VSD occluder in a high-risk patient with recurrent heart failure following multiple myocardial infarctions

Senol Coskun, Saim Sag, Osman Ozdabakoglu, Teoman Kilic

Frontiers in Cardiovascular Medicine · 22.07.2026 · 13

DOI: 10.3389/fcvm.2026.1879721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 22.07.2026. Verfasst von Senol Coskun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Kocaeli Health and Technology University, Kocaeli, Türkiye. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Left ventricular pseudoaneurysm (LVPA) is a rare and potentially fatal complication of myocardial infarction (MI), with mortality reaching 48% in untreated patients. While surgical repair has been the conventional therapy, perioperative mortality of 10%–36% renders it prohibitive in patients with multiple comorbidities. Percutaneous transcatheter closure has emerged as a life-saving alternative for high-risk surgical candidates. Case report A 75-year-old male with prior coronary artery bypass grafting (2010) and two subsequent myocardial infarctions (2019 and 2020) treated with percutaneous coronary intervention presented with refractory decompensated heart failure, massive left pleural effusion, and markedly elevated NT-proBNP (7,172 pg/mL). Cardiac magnetic resonance imaging revealed a giant LVPA (61 mm × 28 mm; end-diastolic volume 55 mL) arising from the lateral-to-posterolateral wall, with transmural late gadolinium enhancement confirming a post-infarction etiology. After multidisciplinary heart-team consensus, percutaneous transcatheter closure was performed via a transfemoral retrograde approach under transesophageal echocardiographic guidance using a 16 mm Amplatzer Muscular VSD Occluder. The procedure was uncomplicated, with no significant residual flow. The patient was discharged on postoperative day 2. At 3-month follow-up, he was in NYHA class I-II with marked symptomatic improvement, NT-proBNP reduction to ∼500 pg/mL, and no residual flow.

Conclusions

Percutaneous transcatheter closure with an Amplatzer Muscular VSD Occluder is a feasible, safe, and life-saving therapeutic option in selected high-risk patients with post-infarction LVPA presenting with refractory heart failure.

Schlagwörter

Stichwörter der Autor:innen

VSD occluder deviceaneurysmfalseheart failureheart ventriclespost myocardial infarction

Autor:innen und Institutionen

  • Faculty of Health Sciences, Kocaeli Health and Technology University, Kocaeli, Türkiye.
  • Department of Cardiology, Acıbadem Bursa Hospital, Bursa, Türkiye.
  • Structural Heart Interventions Unit, Department of Cardiology, Kocaeli University School of Medicine, Kocaeli, Türkiye.

Zitieren

APA

Coskun, S., Sag, S., Ozdabakoglu, O., & Kilic, T. (2026). Percutaneous closure of a giant left ventricular pseudoaneurysm using an Amplatzer muscular VSD occluder in a high-risk patient with recurrent heart failure following multiple myocardial infarctions. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1879721

Vancouver

Coskun S, Sag S, Ozdabakoglu O, Kilic T. Percutaneous closure of a giant left ventricular pseudoaneurysm using an Amplatzer muscular VSD occluder in a high-risk patient with recurrent heart failure following multiple myocardial infarctions. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1879721

BibTeX
@article{Coskun2026,
  author = {Coskun, Senol and Sag, Saim and Ozdabakoglu, Osman and Kilic, Teoman},
  title = {Percutaneous closure of a giant left ventricular pseudoaneurysm using an Amplatzer muscular VSD occluder in a high-risk patient with recurrent heart failure following multiple myocardial infarctions},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1879721}
}
Kostenlos starten →